Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

411 recalls · Class II, newest first

Class II · Moderate risk

Timolol Maleate Ophthalmic Solution

Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.

Terminated Packaging defect FDC Limited NDC 64980-514-05 D-0488-2024
Class II · Moderate risk

Eylea

Lack of Assurance of Sterility: Complaints of syringe breakage

Terminated Sterility / contamination Regeneron Pharmaceuticals Inc NDC 61755-005-01 D-0479-2024
Class II · Moderate risk

minolira (minocycline hydrochloride)

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation EPI Health, LLC NDC 71403-102-30 D-0475-2024
Class II · Moderate risk

minolira (minocycline hydrochloride)

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation EPI Health, LLC NDC 71403-101-30 D-0474-2024
Class II · Moderate risk

Cloderm (clocortolone pivalate)

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation EPI Health, LLC NDC 71403-804-90 D-0473-2024
Class II · Moderate risk

Ful-Glo

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 17478-404-01 D-0465-2024
Class II · Moderate risk

Ful-Glo

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 17478-403-03 D-0464-2024
Class II · Moderate risk

GloStrips

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 51801-009-40 D-0463-2024
Class II · Moderate risk

GloStrips

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 51801-003-40 D-0462-2024
Class II · Moderate risk

Aloe Gator

Out of Specification for active ingredient

Ongoing Failed specification ARG Laboratories, Inc. D-0530-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0529-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0528-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0527-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0526-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0525-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0524-2024

Recalls by year